Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2003
10/30/2003WO2003051378A3 Pharmaceutical composition for topical treatment of skin disorders and skin wounds
10/30/2003WO2003051294A3 Mitocidal compositions and methods
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003047633A3 Treatment of angiogenesis disorders using targeted nanoparticles
10/30/2003WO2003035692A3 Modified peptides and their uses
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003024436A3 Method for treating skin disorders
10/30/2003WO2003020309A3 Compound
10/30/2003WO2003018836A3 Model of autoimmune disease and methods for identifying agents against autoimmune disease
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003014305A3 Eukaryotic cells and method for preserving cells
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002080978A3 Pharmaceutical compositions comprising ascomycin
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002066476A9 6-phenylbenzonaphthyridines
10/30/2003WO2002059607A3 Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002032447A3 Cell damage inhibitor
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2002007700A8 Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
10/30/2003WO2002007685A8 Method of regulating hair growth using metal complexes of oxidized carbohydrates
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203957 Selected fused pyrrolocarbazoles
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203933 Novel curcumin analogues and uses thereof
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203914 Implicated as playing a key role in processes involving cellular invasion and tissue remodelling including wound repair, bone remodelling, angiogenesis, tumour invasiveness and spread of metastases
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203896 Novel guanidino derivatives as inhibitors of cell adhesion
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203882 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203824 Antibacterial soap
10/30/2003US20030203484 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203060 Electrodeposition of very fine metal particles, e.g. copper, in a plant extract juice by electrolysis using the desired metal as an electrode to form a medicinal powder; refining of alloys, e.g., removal of gold metal from an alloy (jewelry)
10/30/2003US20030203052 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
10/30/2003US20030203017 Plaster for topical use containing heparin and diclofenac
10/30/2003US20030203013 Microbial cellulose wound dressing for treating chronic wounds
10/30/2003US20030202994 Excitatory amino acid inhibitors for treating sensitive skins
10/30/2003US20030202965 Vitiligo therapy; tissue engineering
10/30/2003US20030202960 Therapeutic angiogenic factors and methods for their use
10/30/2003US20030202955 Crosslinked polyether binding to protein; biodegradation
10/30/2003US20030202951 Method for reducing the appearance of dark circles under the eyes
10/30/2003US20030202939 Forming oxygen free radicals; destroying tumor, cancer
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2752132A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003CA2636960A1 Pharmaceutical composition comprising a specific inhibitor of hedgehog/smoothened signaling and a corticosteroid
10/30/2003CA2483409A1 (20s)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin d3 and their uses
10/30/2003CA2483311A1 Modulators of hedgehog signaling pathways, compositions and uses related thereto
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481499A1 Use of cyclopamine in the treatment of psoriasis and other skin disorders
10/30/2003CA2481104A1 Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation
10/30/2003CA2481088A1 Use of materials having zinc ionophoric behavior
10/30/2003CA2480451A1 New 2-substituted -1,3-thiazole compounds
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2466229A1 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
10/29/2003EP1357181A1 Novel atopic dermatitis-associated gene and proteins
10/29/2003EP1357130A1 Basic fibroblastic growth factor with a specific collagen binding domain
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1356813A1 Antibacterial compositions comprising metal phthalocyanine analogues
10/29/2003EP1356288A1 Screening assay for cotranslational translocation interfering compounds
10/29/2003EP1356106A2 Method for determining skin stress or skin ageing in vitro
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356034A2 Genes associated with allergic hypersensitivity and mast cell activation
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355893A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/29/2003EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355877A1 Process of obtaining compositions of stable lutein and lutein derivatives
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355873A1 Pleuromutilin derivatives with antimicrobial activity
10/29/2003EP1355682A2 Hydrogel wound dressing and the method of making and using the same
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355643A2 Epoxyvibsanin b
10/29/2003EP1355642A2 INHIBITION OF NF-(k)B BY TRITERPENE COMPOSITIONS
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1355626A2 Veterinary dermatologic composition
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1107940B1 Vitamin d3 mimics
10/29/2003EP0971888B1 2-alkyl-19-nor-vitamin d compounds
10/29/2003EP0957898B1 Personal wash liquid composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers
10/29/2003EP0946736B1 Method for expression of heterologous proteins in yeast
1 ... 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 ... 1065